Souvenaid® can help with the earliest stage of Alzheimer’s Disease in the long-term
Excitingly, the findings of the LipiDiDiet (LDD) Study at 36-months support and extend those concluded at the 24-month marks, confirming that Souvenaid® can help to sustain memory and cognitive performance, the ability to think and perform everyday tasks, as well as reduce brain shrinkage in people with the earliest stage of AD in the long-term. The study confirms the benefit of starting early, and shows that benefits can be sustained over 3 years. 1
“These results show that for those in the early stage of Alzheimer's disease, 3 years of taking Souvenaid daily slows the progression of memory and cognitive decline, and also reduces structural damage in the brain. These results are incredibly important because currently there are no approved treatment options for mild cognitive impairment in New Zealand,” explains Associate Professor Woodward.
Souvenaid® is classed as a food for special medical purposes and is designed to be taken every day. It’s available in NZ from select pharmacies and can be found online at www.souvenaid.co.nz. It’s recommended pharmacists speak with their patients before use to determine whether Souvenaid can benefit them.